Israel’s MetaSight Diagnostics is developing fast, low-cost mass spectrometry to perform vast amounts of serum biopsies of the metabolome (molecules in a cell). These can detect cancer, liver disease, cardiovascular and neurological diseases etc. MetaSight is working with KSM (Maccabi’s … Continue reading →

I reported previously (8th Apr) on Israel’s PixCell which received a multi-million grant by the EU to help advance its HemoScreen portable blood test.  The US FDA has just approved HemoScreen to sell in the USA. Meanwhile, Israel’s SightDx has … Continue reading →

Israel’s Sight Diagnostics (SightDx) (see here) in collaboration with the US Army Medical Research Directorate Kenya (USAMRD-K) is developing a portable malaria and complete blood count (CBC) reader.  It will be calibrated and tested in clinical trials at the USAMRD-K … Continue reading →

The SightDX Parasight Malaria Detection Platform from Israel’s Sight Diagnostics is to be introduced into India.  Approximately 880,000 cases of malaria were reported in India in 2013. http://www.livemint.com/Companies/tawvlTnMXHEnoHjT4K9qvN/Becton-Dickinson-brings-4minute-malaria-detection-kit-to-I.html (See Aug newsletter for more about SightDX)

Israel’s Sight Diagnostics (SightDx) uses computer vision technology to scan “stained” blood samples under a fluorescent microscope and detect the presence of anomalies in blood cells due to malaria. The 3 minute test contrasts with current tests that take one … Continue reading →